Obalon Therapeutics, Inc. (OBLN)
Obalon Therapeutics, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Carlsbad, CA, US. The stock last traded at $3.05, down 5.86% on the session, giving a market capitalisation of $5.5M. On trailing twelve-month figures it carries a trailing P/E of 9.53, a net margin of 494.7%. Its beta of -1.24 implies it has historically moved less than the broad market.
Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The company's flagship offering is the Obalon Balloon System, specifically engineered to promote weight reduction in obese patients. This comprehensive system incorporates an ingestible capsule that houses an inflatable balloon connected to a microcatheter. It also includes the Obalon Navigation System console, a specialized hardware and software platform used to precisely monitor and display the balloon's location during its placement. Further components are the Obalon Touch Inflation Dispenser, a semi-automated, portable instrument for inflating the balloon once it's correctly positioned, and a single-use canister containing a gas mixture. By February 27, 2020, Obalon Therapeutics managed three company-owned treatment centers situated in California. The firm was established in 2008 and bases its operations in Carlsbad, California.
Obalon Therapeutics, Inc. is most often compared with the following Healthcare names: